All information on this website is intended strictly for educational and research purposes only.
The content on OpenPep — including peptide profiles, clinical trial summaries, dosing information, and reconstitution calculators — must not be used for:
OpenPep aggregates publicly available clinical trial data and research. We do not sell, distribute, or recommend any substances. All AI-generated summaries are interpretations of published research and may contain errors.
Cerebrolysin (Porcine Brain-Derived Peptide Mix)
For educational and research purposes only. Not medical advice.
Cerebrolysin is approved in 44+ countries for neurological conditions but not in the US. Extensive clinical data for stroke and TBI recovery. The Cochrane review found moderate evidence for vascular dementia benefit. Unique multi-peptide neurotrophic approach.
Best Time
Morning (IV infusion)
Method
intravenous
Frequency
Daily for 10-20 days per cycle
Half-life
Minutes (individual peptides) but sustained neurotrophin-like effects
Cycle Length
10-20 day courses, repeated quarterly
Storage
Published Dosing Ranges
Create an account to access peptide research data.
Contraindications
Create an account to access peptide research data.
Alzheimer's & dementia : the journal of the Alzheimer's Association 21 (11) :e70840 · 2025-11-01
Stroke 56 (4) :937-947 · 2025-04-01
The Journal of head trauma rehabilitation 39 (5) :342-358 · 2024-01-01
Brain sciences 13 (3) · 2023-03-17
Frontiers in human neuroscience 18 :1457527 · 2024-01-01
Mechanism of Action
Complex mixture of low-molecular-weight neuropeptides and amino acids derived from porcine brain. Mimics endogenous neurotrophic factors (BDNF, GDNF, CNTF) and promotes neuroplasticity.
Reported by the community. These may not be supported by clinical evidence and are not medical recommendations.